Ectopic pregnancy: risk factors, clinical presentation and management

GG Ranji, G Usha Rani, S Varshini - … of Obstetrics and Gynecology of India, 2018 - Springer
Background Ectopic pregnancy is increasing in incidence. Nevertheless, there is wide
availability of tools for early diagnosis and advances in management. Though it is not a …

Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy

J Zhang, Y Zhang, L Gan, X Liu, S Du - BMC Pregnancy and Childbirth, 2020 - Springer
Background Ectopic pregnancy is a major life-and fertility-threatening women's health
concern. As a result of advances in examination technology, an increasing number of …

The use of single dose methotrexate in the management of ectopic pregnancy and pregnancy of unknown location: 10 years' experience in a tertiary center

AM Sindiani, E Alshdaifat, B Obeidat… - … Journal of Women's …, 2020 - Taylor & Francis
Objective To study factors associated with the success of single dose methotrexate (MTX)
treatment in women with ectopic pregnancy. Methods This is a retrospective study of women …

[PDF][PDF] Predictive factors of methotrexate treatment success in ectopic pregnancy: A single-center tertiary study

C Pulatoglu, O Dogan, A Basbug, AE Kaya… - North Clin …, 2018 - jag.journalagent.com
ABSTRACT OBJECTIVE: It is controversial whether medical or surgical treatment options
have more successful results in ectopic pregnancy treatment. Although high pretreatment …

[HTML][HTML] Single-dose methotrexate for the treatment of ectopic pregnancy: Our experience from 2010 to 2015

EE Tas, GFY Akcay, AF Avsar - Pakistan journal of medical …, 2017 - ncbi.nlm.nih.gov
Objective: To evaluate the success of systemic single-dose methotrexate (MTX) treatment in
patients with ectopic pregnancy (EP) and to investigate factors related to treatment success …

[PDF][PDF] Pretreatment serum human chorionic gonadotropin cutoff value for medical treatment success with single-dose and multi-dose regimen of methotrexate in tubal …

J Kim, YM Jung, DY Lee… - Obstetrics & gynecology …, 2017 - synapse.koreamed.org
Objective To investigate individual pretreatment serum human chorionic gonadotropin
(hCG) cutoff value for medical treatment success with single-dose and multi-dose regimen of …

Clinical characteristics of persistent ectopic pregnancy after salpingostomy and influence on ongoing pregnancy

Y Zhang, J Chen, W Lu, B Li, G Du… - Journal of Obstetrics and …, 2017 - Wiley Online Library
Aim The aim of this study was to assay the clinical characteristics of persistent ectopic
pregnancy (PEP) and its influence on ongoing pregnancy. Methods We retrospectively …

Role of day 4 HCG as an early predictor of success after methotrexate therapy for ectopic pregnancies

S Girija, AP Manjunath, A Salahudin… - European Journal of …, 2017 - Elsevier
Objective To validate whether change in serum HCG levels between days 0 and 4 confer
any prognostic value during methotrexate therapy and to quantify its change. Study design …

[HTML][HTML] Treatment success with two doses of methotrexate vs single dose of methotrexate in Ectopic Tubal Pregnancy

M Khakwani, R Parveen, S Ali - Pakistan Journal of Medical …, 2022 - ncbi.nlm.nih.gov
Objectives: To compare the success rates and safety of two-doses of methotrexate versus
single dose of methotrexate in ectopic tubal pregnancy. Methods: This was an open-label …

The predictors of successful methotrexate treatment of tubal ectopic pregnancy

E Abdelfattah-Arafa, HF Abdussalam… - Journal of Obstetrics …, 2024 - Taylor & Francis
Background The pre-treatment characteristics of the patient and ectopic pregnancy to
determine the patients who are likely to successfully respond to methotrexate (MTX) therapy …